研究文章
慢性抗凝质量控制颅内出血患者由于维生素K拮抗剂
|
| 基线特征(N = 53) |
|
| 年龄、中值(范围)年 |
79 (56 - 93) |
|
| 性别(女) |
26 (42%) |
|
| 以前的夫人N (%) |
|
| (我)0 - 3 |
41 (91%) |
| (2)4 - 5 |
4 (9%) |
|
| 动脉高血压N (%) |
4 (9%) |
|
| 糖尿病N (%) |
13 (25%) |
|
| 血脂异常N (%) |
23 (43%) |
|
| 之前的行程: |
|
| (我)TIA N (%) |
7 (13.21%) |
| (2)缺血性N (%) |
2 (5%) |
| (3)出血热N (%) |
3 (6.5%) |
| (iv) N (%) |
2 (5%) |
|
| HASBLED值(p25-p75) |
2.5 (2 - 3) |
|
| 乍得2年代2-VASc值(p25-p75) |
4 (3 - 5) |
|
| 条件需要抗凝治疗: |
|
| (我)心房纤颤N (%) |
48 (90.6%) |
| (2)机械心脏瓣膜N (%) |
5 (9.4%) |
|
| 伴随药物: |
|
| (我)抗血小板药物N (%) |
3 (6.5%) |
| (2)他汀类药物N (%) |
19 (43.2%) |
|
| Leukoaraiosis N (%) |
24 (47%) |
|
|
|
蒂雅:短暂性缺血性发作。VKA:维生素K拮抗剂。
|
